670 related articles for article (PubMed ID: 21714643)
21. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
[TBL] [Abstract][Full Text] [Related]
22. Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
Hori T; Ohnishi H; Teramoto T; Tsubouchi K; Naiki T; Hirose Y; Ohara O; Seishima M; Kaneko H; Fukao T; Kondo N
J Clin Immunol; 2012 Dec; 32(6):1213-20. PubMed ID: 22847544
[TBL] [Abstract][Full Text] [Related]
23. Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3.
Al Rushood M; McCusker C; Mazer B; Alizadehfar R; Grimbacher B; Depner M; Ben-Shoshan M
J Pediatr; 2013 Jul; 163(1):277-9. PubMed ID: 23541088
[TBL] [Abstract][Full Text] [Related]
24. Immunology. An innate role for IL-17.
Dominguez-Villar M; Hafler DA
Science; 2011 Apr; 332(6025):47-8. PubMed ID: 21454778
[No Abstract] [Full Text] [Related]
25. The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
Depner M; Fuchs S; Raabe J; Frede N; Glocker C; Doffinger R; Gkrania-Klotsas E; Kumararatne D; Atkinson TP; Schroeder HW; Niehues T; Dückers G; Stray-Pedersen A; Baumann U; Schmidt R; Franco JL; Orrego J; Ben-Shoshan M; McCusker C; Jacob CM; Carneiro-Sampaio M; Devlin LA; Edgar JD; Henderson P; Russell RK; Skytte AB; Seneviratne SL; Wanders J; Stauss H; Meyts I; Moens L; Jesenak M; Kobbe R; Borte S; Borte M; Wright DA; Hagin D; Torgerson TR; Grimbacher B
J Clin Immunol; 2016 Jan; 36(1):73-84. PubMed ID: 26604104
[TBL] [Abstract][Full Text] [Related]
26. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
27. Recurrent inflammatory aortic aneurysms in chronic mucocutaneous candidiasis with a gain-of-function STAT1 mutation.
Tanimura M; Dohi K; Hirayama M; Sato Y; Sugiura E; Nakajima H; Kanemitsu S; Toyoda H; Yamada N; Masuya M; Imanaka-Yoshida K; Shimpo H; Azuma E; Ito M
Int J Cardiol; 2015 Oct; 196():88-90. PubMed ID: 26080282
[No Abstract] [Full Text] [Related]
28. Case Report: Disseminated
Chen K; Tan J; Qian S; Wu S; Chen Q
Front Immunol; 2021; 12():682350. PubMed ID: 34421897
[TBL] [Abstract][Full Text] [Related]
29. Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis.
Ifrim DC; Quintin J; Meerstein-Kessel L; Plantinga TS; Joosten LA; van der Meer JW; van de Veerdonk FL; Netea MG
Clin Exp Immunol; 2015 Sep; 181(3):434-40. PubMed ID: 25880788
[TBL] [Abstract][Full Text] [Related]
30. [Chronic mucocutaneous candidiasis with STAT1 gain-of-function mutation associated with herpes virus and mycobacterial infections].
Baghad B; Benhsaien I; El Fatoiki FZ; Migaud M; Puel A; Chiheb S; Bousfiha AA; Ailal F
Ann Dermatol Venereol; 2020 Jan; 147(1):41-45. PubMed ID: 31677808
[TBL] [Abstract][Full Text] [Related]
31. A gain-of-function mutation of STAT1: A novel genetic factor contributing to chronic mucocutaneous candidiasis.
Eslami N; Tavakol M; Mesdaghi M; Gharegozlou M; Casanova JL; Puel A; Okada S; Arshi S; Bemanian MH; Fallahpour M; Molatefi R; Seif F; Zoghi S; Rezaei N; Nabavi M
Acta Microbiol Immunol Hung; 2017 Jun; 64(2):191-201. PubMed ID: 28597685
[TBL] [Abstract][Full Text] [Related]
32. Orf Infection in a Patient with Stat1 Gain-of-Function.
Kilic SS; Puel A; Casanova JL
J Clin Immunol; 2015 Jan; 35(1):80-3. PubMed ID: 25367169
[TBL] [Abstract][Full Text] [Related]
33. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
Front Immunol; 2018; 9():2570. PubMed ID: 30510552
[TBL] [Abstract][Full Text] [Related]
34. IL-17 T cells' defective differentiation in vitro despite normal range ex vivo in chronic mucocutaneous candidiasis due to STAT1 mutation.
Mekki N; Ben-Mustapha I; Liu L; Boussofara L; Okada S; Cypowyj S; Ghariani N; Saidi W; Denguezli M; Casanova JL; Puel A; Barbouche MR
J Invest Dermatol; 2014 Apr; 134(4):1155-1157. PubMed ID: 24335902
[No Abstract] [Full Text] [Related]
35. Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.
Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
Arch Dermatol Res; 2007 Dec; 299(10):475-81. PubMed ID: 17960405
[TBL] [Abstract][Full Text] [Related]
36. Identification of a distinct subset of disease-associated gain-of-function missense mutations in the STAT1 coiled-coil domain as system mutants.
Petersen J; Staab J; Bader O; Buhl T; Ivetic A; Meyer T
Mol Immunol; 2019 Oct; 114():30-40. PubMed ID: 31336247
[TBL] [Abstract][Full Text] [Related]
37. A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
Nielsen J; Kofod-Olsen E; Spaun E; Larsen CS; Christiansen M; Mogensen TH
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494717
[TBL] [Abstract][Full Text] [Related]
38. Double Trouble? CMC with a Mutation in both AIRE and STAT1.
Al Dhanhani H; Al Shehri T; Lilic D; Buddles M; Kisand K; Maccari ME; Leahy TR
J Clin Immunol; 2018 Aug; 38(6):635-637. PubMed ID: 30054782
[No Abstract] [Full Text] [Related]
39. The pathogenic T387A missense mutation in the gene encoding signal transducer and activator of transcription 1 exhibits a differential gene expression profile.
Staab J; Schwämmle T; Meyer T
Mol Immunol; 2020 Dec; 128():79-88. PubMed ID: 33096415
[TBL] [Abstract][Full Text] [Related]
40. Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.
Okada S; Asano T; Moriya K; Boisson-Dupuis S; Kobayashi M; Casanova JL; Puel A
J Clin Immunol; 2020 Nov; 40(8):1065-1081. PubMed ID: 32852681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]